Integrated epigenetic and transcriptomic analysis reveals low CD83 on B cells linked to refractory anti-PLA2R-associated membranous nephropathy

Background Anti-phospholipase A2 receptor (anti-PLA2R)-associated membranous nephropathy (MN) is a primary form of autoimmune glomerulonephritis causing nephrotic syndrome. MN can develop a refractory or relapsing clinical course, but biomarkers associated with poor prognosis remain poorly defined. Methods We performed single-nucleus RNA-sequencing (snRNA-seq) and ATAC-sequencing (snATAC-seq) of peripheral immune cells from five refractory/relapsing MN, six remission MN, twelve disease-control and seven healthy individuals (HCs), and GeoMx spatial transcriptomics of diagnostic kidney biopsies from eight refractory/relapsing MN, eight remission MN and eight HCs. Results B cells from refractory/relapsing MN showed significantly reduced CD83 expression. After re-clustering B cells according to CD83 expression, we found that the CD83-high B cells, characterized by upregulation of BACH2, FOXP1, and FOXO1 exhibited significantly lower CD83 expression in the refractory/relapsing MN. Regulatory T cells (Tregs) were also reduced in refractory/relapsing MN. Conversely, glomerular transcriptomes showed minimal differences between refractory/relapsing and remission MN. Conclusions Our findings suggest that CD83-high B cells and Tregs are potential biomarkers and therapeutic targets for refractory/relapsing MN.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1957278
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated epigenetic and transcriptomic analysis reveals low CD83 on B cells linked to refractory anti-PLA2R-associated membranous nephropathy

Christine Suh-Yun Joh, Ji Hwan Moon, Nicholas J. Steers, Seung Seok Han et al.
2 links
Frontiers in Immunology
Renal Diseases and Glomerulopathies
article

Integrated epigenetic and transcriptomic analysis reveals low CD83 on B cells linked to refractory anti-PLA2R-associated membranous nephropathy

Christine Suh-Yun Joh, Ji Hwan Moon, Nicholas J. Steers, Seung Seok Han, Jang Hee Han, Donggun Kim, Kwon Wook Joo, Chang Wook Jeong, Jong-Il Kim, Kookhwan Oh, Yong Chul Kim, Dong Ki Kim, Hajeong Lee, Minji Kang, Seung Hee Yang, Sehoon Park, Seong Min Lee, Hyun Je Kim
article en

Abstract

Background Anti-phospholipase A2 receptor (anti-PLA2R)-associated membranous nephropathy (MN) is a primary form of autoimmune glomerulonephritis causing nephrotic syndrome. MN can develop a refractory or relapsing clinical course, but biomarkers associated with poor prognosis remain poorly defined. Methods We performed single-nucleus RNA-sequencing (snRNA-seq) and ATAC-sequencing (snATAC-seq) of peripheral immune cells from five refractory/relapsing MN, six remission MN, twelve disease-control and seven healthy individuals (HCs), and GeoMx spatial transcriptomics of diagnostic kidney biopsies from eight refractory/relapsing MN, eight remission MN and eight HCs. Results B cells from refractory/relapsing MN showed significantly reduced CD83 expression. After re-clustering B cells according to CD83 expression, we found that the CD83-high B cells, characterized by upregulation of BACH2, FOXP1, and FOXO1 exhibited significantly lower CD83 expression in the refractory/relapsing MN. Regulatory T cells (Tregs) were also reduced in refractory/relapsing MN. Conversely, glomerular transcriptomes showed minimal differences between refractory/relapsing and remission MN. Conclusions Our findings suggest that CD83-high B cells and Tregs are potential biomarkers and therapeutic targets for refractory/relapsing MN.

Frontiers in ImmunologyVol. 17
Seoul National University (KR), Columbia University Irving Medical Center (US), Samsung Medical Center (KR), Seoul National University Hospital (KR), Columbia University (US)
Seoul National University, Korea Health Industry Development Institute, National Research Foundation of Korea, Seoul National University Hospital, Daewoong Pharmaceutical Company, Ministry of Science and ICT, South Korea, Korea National Institute of Health
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon